VCIM
Velan Capital Investment Management Portfolio holdings
AUM
$99.9M
This Quarter Return
+25.84%
1 Year Return
+37.46%
3 Year Return
+659.14%
5 Year Return
–
10 Year Return
–
AUM
$107M
AUM Growth
+$107M
(-5.6%)
Cap. Flow
-$4.37M
Cap. Flow
% of AUM
-4.11%
Top 10 Holdings %
Top 10 Hldgs %
66.39%
Holding
38
New
6
Increased
9
Reduced
4
Closed
7
Top Buys
| 1 |
ALIM
Alimera Sciences, Inc.
ALIM
|
$4.09M |
| 2 |
IMGN
Immunogen Inc
IMGN
|
$3.58M |
| 3 |
InspireMD
NSPR
|
$2.27M |
| 4 |
MoonLake Immunotherapeutics
MLTX
|
$1.63M |
| 5 |
Geron
GERN
|
$1.54M |
Top Sells
| 1 |
Immunocore
IMCR
|
$9.89M |
| 2 |
ADMA Biologics
ADMA
|
$4.7M |
| 3 |
Lantheus
LNTH
|
$4.2M |
| 4 |
Terns Pharmaceuticals
TERN
|
$1.42M |
| 5 |
PNT
POINT Biopharma Global Inc. Common Stock
PNT
|
$1.37M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Jasper Therapeutics
JSPR
$45.5M
| $14.8M | 13.79% | 11,219,036 | – | – |
|
|
2
ADMA Biologics
ADMA
$4.12B
| $10.1M | 9.34% | 2,726,051 -1,273,949 | -32% | -$4.7M |
|
|
3
Lantheus
LNTH
$3.73B
| $8.39M | 7.79% | 100,000 -50,000 | -33% | -$4.2M |
|
4
TELA Bio
TELA
$70.5M
| $7.56M | 7.02% | 746,087 | – | – |
|
5
Praxis Precision Medicines
PRAX
$958M
| $5.96M | 5.54% | 5,185,000 | – | – |
|
6
Heron Therapeutics
HRTX
$207M
| $5.22M | 4.85% | 4,500,000 | – | – |
|
|
QIPT
7
Quipt Home Medical
QIPT
$114M
| $5.18M | 4.81% | 970,000 +170,000 | +21% | +$908K |
|
|
ALIM
8
DELISTED
Alimera Sciences, Inc.
ALIM
| $4.85M | 4.5% | 1,659,654 +1,401,901 | +544% | +$4.09M |
|
|
OPTN
9
DELISTED
OptiNose
OPTN
| $4.42M | 4.11% | 3,596,861 +100,000 | +3% | +$123K |
|
10
Tenet Healthcare
THC
$16.3B
| $4.22M | 3.92% | 51,900 | – | – |
|
|
IMGN
11
DELISTED
Immunogen Inc
IMGN
| $3.58M | 3.32% | +189,500 | New | +$3.58M |
|
12
Cabaletta Bio
CABA
$133M
| $3.23M | 3% | 250,000 | – | – |
|
|
GRTX
13
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $3.12M | 2.9% | 1,000,000 | – | – |
|
|
PNT
14
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $3.11M | 2.88% | 342,936 -151,200 | -31% | -$1.37M |
|
|
15
MoonLake Immunotherapeutics
MLTX
$3.54B
| $2.82M | 2.62% | 55,300 +31,900 | +136% | +$1.63M |
|
|
16
Geron
GERN
$893M
| $2.5M | 2.32% | 778,500 +478,500 | +160% | +$1.54M |
|
|
17
InspireMD
NSPR
$102M
| $2.27M | 2.11% | +904,029 | New | +$2.27M |
|
|
CTLT
18
DELISTED
CATALENT, INC.
CTLT
| $2.17M | 2.01% | 50,000 | – | – |
|
19
89bio
ETNB
$1.34B
| $1.8M | 1.67% | 95,000 -3,500 | -4% | -$66.3K |
|
20
Iovance Biotherapeutics
IOVA
$807M
| $1.69M | 1.57% | 240,000 +20,000 | +9% | +$141K |
|
|
AVDL
21
Avadel Pharmaceuticals
AVDL
$1.43B
| $1.65M | 1.53% | 100,000 +74,257 | +288% | +$1.22M |
|
22
Annexon
ANNX
$226M
| $1.62M | 1.5% | 459,746 +359,746 | +360% | +$1.27M |
|
|
ICVX
23
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $1.6M | 1.48% | 160,630 +10,630 | +7% | +$106K |
|
24
Edesa Biotech
EDSA
$16.3M
| $1.04M | 0.97% | 1,281,615 | – | – |
|
25
InflaRx
IFRX
$108M
| $892K | 0.83% | +200,000 | New | +$892K |
|